99 related articles for article (PubMed ID: 20026244)
1. Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells.
Joo SH; Kwon KJ; Kim JW; Kim JW; Hasan MR; Lee HJ; Han SH; Shin CY
Neurosci Lett; 2010 Jan; 469(3):352-6. PubMed ID: 20026244
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
3. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes.
Arai K; Lee SR; Lo EH
Glia; 2003 Sep; 43(3):254-64. PubMed ID: 12898704
[TBL] [Abstract][Full Text] [Related]
4. The effects of IL-32 on the inflammatory activation of cultured rat primary astrocytes.
Cho KS; Park SH; Joo SH; Kim SH; Shin CY
Biochem Biophys Res Commun; 2010 Nov; 402(1):48-53. PubMed ID: 20888796
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.
Lee EJ; Woo MS; Moon PG; Baek MC; Choi IY; Kim WK; Junn E; Kim HS
J Immunol; 2010 Jul; 185(1):615-23. PubMed ID: 20511551
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
Itatsu K; Sasaki M; Harada K; Yamaguchi J; Ikeda H; Sato Y; Ohta T; Sato H; Nagino M; Nimura Y; Nakanuma Y
Liver Int; 2009 Feb; 29(2):291-8. PubMed ID: 18710428
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia.
Liuzzi GM; Mastroianni CM; Latronico T; Mengoni F; Fasano A; Lichtner M; Vullo V; Riccio P
Brain; 2004 Feb; 127(Pt 2):398-407. PubMed ID: 14662518
[TBL] [Abstract][Full Text] [Related]
9. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
11. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
Heidinger M; Kolb H; Krell HW; Jochum M; Ries C
Biol Chem; 2006 Jan; 387(1):69-78. PubMed ID: 16497166
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D.
Bahar-Shany K; Ravid A; Koren R
J Cell Physiol; 2010 Mar; 222(3):729-37. PubMed ID: 20020446
[TBL] [Abstract][Full Text] [Related]
13. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.
Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY
Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
He S; Prasanna G; Yorio T
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
[TBL] [Abstract][Full Text] [Related]
16. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
Lee DY; Oh YJ; Jin BK
Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
[TBL] [Abstract][Full Text] [Related]
18. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidic acid as a regulator of matrix metalloproteinase-9 expression via the TNF-alpha signaling pathway.
Lee JG; Lee SH; Park DW; Bae YS; Yun SS; Kim JR; Baek SH
FEBS Lett; 2007 Feb; 581(4):787-93. PubMed ID: 17276429
[TBL] [Abstract][Full Text] [Related]
20. Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke.
Guo M; Lin V; Davis W; Huang T; Carranza A; Sprague S; Reyes R; Jimenez D; Ding Y
J Cereb Blood Flow Metab; 2008 Aug; 28(8):1422-30. PubMed ID: 18414498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
